
Sign up to save your podcasts
Or


Pharmaceutical companies are continuously evaluating the efficiency of their filling lines to achieve lower costs, better quality and higher flexibility. Three slightly contradictory goals require a fundamental rethinking of manufacturing processes. This session addresses the core challenges and how ready-to-use (RTU) vials like adaptiQ® from SCHOTT Pharma can help to improve the drug quality and accelerate time-to-market and as a result reduce the Total Cost of Ownership of fill-and-finish processes.
Learn more about your ad choices. Visit megaphone.fm/adchoices
By SCHOTT PharmaPharmaceutical companies are continuously evaluating the efficiency of their filling lines to achieve lower costs, better quality and higher flexibility. Three slightly contradictory goals require a fundamental rethinking of manufacturing processes. This session addresses the core challenges and how ready-to-use (RTU) vials like adaptiQ® from SCHOTT Pharma can help to improve the drug quality and accelerate time-to-market and as a result reduce the Total Cost of Ownership of fill-and-finish processes.
Learn more about your ad choices. Visit megaphone.fm/adchoices